SABIC Boosts African Agri-nutrients Presence with ETG Stake

SABIC Agri-Nutrients has agreed to acquire a 49% stake in ETG Inputs Holdco for an enterprise value of $320 million. ETG Inputs Holdco blends and distributes fertilizers, seeds and crop protection products across Africa from its more than 350 distribution centers.

The agreement is part of SABIC Agri-Nutrients’ strategy to move closer to farmers and end-customers in global agri-nutrient markets. The Saudi petrochemicals group said the transaction is subject to obtaining the necessary regulatory approvals and will be financed by the company’s own resources in addition to bank facilities.

“This move will help us expand our footprint taking advantage of growth opportunities to keep up with expected developments and to position the company as a leading player in the global agri-nutrients industry with the best-in-class capabilities in manufacturing, operation, planning, marketing, sales, supply chain, technology and research, and aftermarket services,” said SABIC Agri-Nutrients’ CEO Abdulrahman Shamsaddin.

SABIC Agri-Nutrients, which is owned 50.1% by SABIC, was launched in 2020 with the aim of becoming “the national champion and a global leader in the agri-nutrients industry.” It was previously known as Saudi Arabian Fertilizer Company (SAFCO).

Author: Elaine Burridge, Freelance Journalist

 

(c) SABIC
(c) SABIC

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read